在炎症性瘤微环境中调节性T细胞的重编程:它可以成为免疫治疗的转折点吗?
Jinming Liu1, Biao Zhang1, Guolin Zhang2
1Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Frontiers in immunology
|March 7, 2024
概括
向瘤中的调节性T细胞 (Tregs) 是癌症免疫治疗的关键. 了解Treg重编程机制可以通过减少免疫抑制和增强抗瘤反应来改善治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 癌症免疫疗法面临来自免疫抑制瘤微环境的挑战.
- 调节性T细胞 (Tregs) 在维持耐受性方面至关重要,但可以被瘤重编程以抑制抗瘤免疫力.
- 目前的Treg消耗疗法有严重的自身免疫副作用的风险.
研究的目的:
- 审查瘤微环境中Treg重编程的机制.
- 为了探索Treg细胞免疫疗法策略.
- 为了确定癌症治疗的新治疗点.
主要方法:
- 关于Treg细胞重编程机制的综合文献综述.
- 对Treg细胞免疫疗法应用的分析.
- 探索用于Treg调制的分子标.
主要成果:
- 在瘤中的Treg重编程促进免疫逃脱和进展.
- 干扰Treg重编程通路可以减少免疫抑制并增强抗瘤免疫力.
- 针对Treg重编程提供了一个有希望的策略,以提高癌症免疫疗法的疗效.
结论:
- 了解Treg重编程对于开发有效的癌症免疫疗法至关重要.
- 调节Treg重编程通路可以选择性地准与瘤相关的Treg,最大限度地降低系统毒性.
- 对Treg重编程机制的进一步研究可能会发现新的治疗点.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K